MedCity News

OCTOBER 18, 2022

According to the motion, more than one third of Planned Parenthood South Atlantic’s abortion patients between July 1 and September 30, 2022 came from out of state, totalling 1,317 people. In the same time period last year, just 322 patients came from out of state for abortions.

Physicians 96

Physicians Medical Patients Biopharma 96

MedCity News

DECEMBER 20, 2022

billion annually on low-value screening, testing, and procedures considered waste, there needs to be a new approach to how the lab industry develops test menus from which physicians order labs. With the projection that the U.S. may spend up to $27.9

Physicians 118

Physicians Biopharma 118

pharmaphorum

NOVEMBER 18, 2022

Physician-scientist led biotech Regeneron will be responsible for funding preclinical and clinical development and commercialisation activities, while oncology-focused biopharma CytomX will receive $30 million in an upfront payment , with the potential for up to $2 billion in research, development, regulatory, and sales-based milestones, also.

Biopharma 94

Biopharma Physicians Sales Patients 94

Pharmaceutical Technology

APRIL 25, 2023

The new system can be integrated with biopharma or provider-facing platforms to enable the exchange of information in real time. It aims to streamline the path-to-care process by providing greater visibility across the therapy development and delivery process for physicians and patient services teams.

Customer Relationship Management 52

Customer Relationship Management Healthcare Provider Relationship management Distribution 52

MedCity News

JULY 8, 2022

The AMA believes physicians should still be the main prescribers, while advocates for provider status for pharmacists say it’s a win for health equity and will expand treatment access.

FDA 115

FDA Physicians Medical Biopharma 115

MedCity News

DECEMBER 18, 2022

Many (not all) physician-/scientist-CEOs have a tendency to revert to their area of comfort by using highly scientific terminology and concepts in ways that derail from the purpose of the presentation: articulating the business case in a finite amount of meeting time.

Marketing 102

Marketing Physicians Biopharma 102

The Marketing Advantage

MAY 8, 2023

Long/Difficult Road to Diagnosis It often takes years and several physicians to reach a diagnosis Knowing the types of physicians that patients are likely to see on their road to diagnosis means companies can pursue those physicians to drive early diagnosis and treatment.

Sales 52

Sales Physicians Consulting Education 52

Prognos Health

FEBRUARY 1, 2022

Small and midsize pharmaceutical companies have fewer resources to dedicate to key commercialization steps such as patient and physician targeting , real-world data (RWD) curation and analysis , market share calculations, patient journey evaluations , and tracking and influencing physician prescribing behavior. Rosenorn, P. Jacquet, D.

Consulting 52

Consulting Physicians Pharma Biopharma 52

PM360

DECEMBER 14, 2023

“We’re now leveraging our expertise in communicating with healthcare professionals to deliver essential information and practical tools to physicians and other healthcare providers to help them address the challenges faced by patients with chronic illness.”

Physicians 52

Physicians Pharma Medical Patients 52

Clarivate

OCTOBER 25, 2023

Unlike in Part D, Part B drugs are physician administered and there is less certainty regarding which drugs will be tapped for negotiations (i.e., How the IRA could affect treatment choice While price negotiations are intended to lower Medicare costs, they also present a challenge to physician practice economics.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Clarivate

DECEMBER 14, 2021

2021 surveys of patients and physicians in the United States conducted by Clarivate show that: Much of care delivery has gone virtual. Three in five physicians in the United States (60%) report having conducted virtual consultations, as do 35% of patients. physicians; Source: Clarivate, Taking the Pulse(R) U.S.

Pharma 52

Pharma Healthcare Healthcare Physicians 52

pharmaphorum

JUNE 12, 2017

Biopharma companies must take into account a multitude of factors when considering physician prescribing behaviors, and need a more integrated "pull-through" strategy across their teams, from managed markets, to marketing, to field sales.

Marketing 52

Marketing Engineering Biopharma Prescription 52

Clarivate

APRIL 24, 2023

CVS then began affiliating with health systems across the country (like Cleveland Clinic ) for physician oversight of MinuteClinic’s staffed midlevel providers, just as Walgreens was rising as a formidable competitor in the convenient care space through its own walk-in clinics that it launched in fall 2006. Key acquisitions by U.S.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

pharmaphorum

OCTOBER 18, 2022

It will create a Nasdaq-listed biopharmaceutical company under the name “Oculis Holding SA”, placing Oculis in position to become a leading global ophthalmic biopharma, with product candidates to address areas of significant medical needs affecting a growing number of patient populations.

Biopharma 57

Biopharma Management Specialization Physicians 57

Clarivate

APRIL 18, 2024

But, even without Amedisys, the insurer still has home healthcare company LHC Group, acquired in early 2023, and will leverage a long-term partnership with Walmart plus the nation’s largest network of employed and affiliated physicians through Optum to manage patient health and drive down costs for vulnerable patients.

Retail 52

Retail Healthcare Healthcare Physicians 52

pharmaphorum

DECEMBER 9, 2022

Nasdaq: AUTL), a clinical-stage biopharma and a portfolio company of Syncona Ltd., Autolus Therapeutic Plc.

Food and Drug Administration 90

Food and Drug Administration Safety Biopharma Patients 90

Clarivate

JULY 5, 2023

and European physicians across six specialties, and global pipeline analysis curated by experts to provide insights into the evolving landscape. Clarivate research indicates biosimilar competition will drive down prices and relative market share of HUMIRA ® in the U.S. from 91% in 2023 to 36% by 2031.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Pharmaceutical Technology

SEPTEMBER 8, 2022

The speciality drug channel participants, including speciality pharmacies, biopharma companies, and distributors, are transforming their operations with automated and secure data systems and next-generation analytics, which will improve data collection, partner performance and strategy effectiveness. Adherence management.

Specialization 45

Specialization Leads Pharma Side effects 45

PM360

MAY 21, 2024

sarah.caldwell@veeva.com SARAH CALDWELL General Manager Veeva Crossix Analytic Consumers’ TV viewing habits are changing, and streaming video continues to catapult in popularity, unearthing new opportunities for biopharma advertisers to reach patients in more targeted ways. According to Nielsen, streaming accounts for 38% of viewership hours.

Media 52

Media Healthcare Healthcare Marketing 52

Pharma Marketing Network

MARCH 25, 2022

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. Extension of the patient: expanding the role of caregivers in biopharma development. But one key member is often omitted: the patient’s caregiver. Caregiving for family and friends — a public health issue.

Pharma 98

Pharma Education Transportation Training 98

PM360

NOVEMBER 27, 2023

I recently sat down with Erica Taylor, PhD, Vice President and Chief Marketing Officer at Genentech, to talk about the future of biopharma marketing and creating more meaningful content.

Marketing 105

Marketing Customer Relationship Management Relationship management Education 105

The Marketing Advantage

JULY 10, 2023

July 10, 2023 One of the functions most critical to maximizing the productivity and efficiency of the sales force’s efforts is call planning —how often a physician target should be seen by a sales representative. Why Don’t Sales Representatives Follow Call Plans?

Sales 40

Sales Consulting Specialization Prospecting 40

Eversana Intouch

FEBRUARY 23, 2023

Biopharma valuations are down, especially for public and earlier-stage companies. There] is a lot of work underway right now to transform the way patients, physicians, and other stakeholders connect with a brand or product. Life-sciences companies need to embrace this and continue to drive digital engagement.”

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Biopharma valuations are down, especially for public and earlier-stage companies. There] is a lot of work underway right now to transform the way patients, physicians, and other stakeholders connect with a brand or product. Life-sciences companies need to embrace this and continue to drive digital engagement.”

Marketing 52

Marketing Pharma Patients Insurance 52

Veeva

AUGUST 15, 2021

Some of the largest pharmaceutical companies in the world, as well as emerging biopharma, use Veeva OpenData to increase field force effectiveness, boost productivity and enhance customer engagement. This enables field reps to target the right physicians and opportunities in real time.

Sales 52

Sales Healthcare Healthcare Healthcare Provider 52

Clarivate

AUGUST 17, 2022

Grace tells us about her experience as a physician and discusses healthcare literacy and education at the point of care. Better access to physicians and better funding of health systems in general are therefore among the many targets listed under SDG 3: Good health and wellbeing. Did you get a lot of resistance to what you were doing?

Healthcare 52

Healthcare Healthcare Patients Physicians 52

The Marketing Advantage

JANUARY 30, 2023

Conclusion Despite their popularity for biopharma product launches, forced rank sales compensation plans are a dangerous choice for this stage of the product life cycle as they ultimately disengage the sales force during the stage that is most critical to securing the product’s long-term success. target payout).

Sales 40

Sales Consulting Biopharma Leads 40

Clarivate

MAY 21, 2024

Furthermore, OS does not capture the broader priorities of patients and physicians; for example, when quality of life is a priority over prolonging survival [2]. Measurement of OS is also susceptible to confounding, particularly when involving multiple lines of therapies, patient crossover, and the occurrence of non-cancer related deaths.

Food and Drug Administration 52

Food and Drug Administration Patients Consulting Marketing 52

Clarivate

JUNE 22, 2023

Questions such as where the patients are, and who and where the prescribing physicians are, can now be answered with pinpoint accuracy. The inclusion of advanced analytics enables RWD to go further than ever before, creating a complementary and robust data set that describes the market for a particular drug.

Patients 52

Patients Electronics Distribution Medical 52

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. Which physicians see these patients? sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Clarivate

MARCH 12, 2024

For the approximately 10% of biopharma candidates that actually manage to make it to clinical trials, many fail to achieve enough revenue once they reach the market to justify the R&D effort. In fact, one-third of drugs launched over a recent 10-year period fell short of sales expectations.

Government 52

Government Physicians Marketing Biopharma 52

pharmaphorum

JANUARY 11, 2023

Roche tops biopharma partnering podium. One in five partnerships were with healthcare systems and providers, which are being “driven by a need for greater productivity and are demanding end to-end solutions that don’t require a patchwork of software solutions or apps for a single patient or physician,” says the report.

Biopharma 74

Biopharma Specialization Physicians Healthcare 74

MedCity News

NOVEMBER 13, 2023

We are on the edge of rapid innovation in psychiatry. Now is the time to break out of our silos and take advantage of the promise the future holds.

Physicians 112

Physicians FDA Biopharma 112

Clarivate

DECEMBER 6, 2022

Renown’s affiliation with the University of Nevada, Reno School of Medicine, will boost local physician rolls and increase integration with area providers.

Networking 52

Networking Healthcare Healthcare Competition 52

MedCity News

MARCH 7, 2023

With the rapid digitization of the entire industry and a new generation of talent waiting in the wings, Medical affairs teams need access to data and modern technology to engage with a new generation of influencers, improve diversity, and develop stronger go-to-market strategies.

Medical 105

Medical Marketing Physicians Biopharma 105

PM360

SEPTEMBER 21, 2023

This “synchronization” helps biopharmas such as Pfizer maximize marketing and field efforts across their organizations to improve engagement with healthcare professionals (HCPs). However, many biopharmas fail to synchronize engagement and digital touchpoints in a timely manner for 73% of HCPs.

Marketing 105

Marketing Media CRM Sales 105

Clarivate

OCTOBER 10, 2022

The biochemically recurrent treatment setting is heterogenous with no clear consensus on timing of hormonal therapy and duration of therapy among physicians. If approved, ERLEADA is likely to compete with Pfizer’s XTANDI®, which is also poised to enter this setting and may benefit from greater physician familiarity. Key ESMO findings.

Marketing 52

Marketing Safety Patients Competition 52